TGFB1 and Alzheimer disease: We found positive enrichment in signaling pathways linked to translation, neuroplasticity, and cytoskeletal regulation, including mTOR, CDC42, TGFβ, neurotrophin signaling, and regulation of actin cytoskeleton, all of which have been shown to be regulated by AD treatment.